Results 211 to 220 of about 68,171 (350)

Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model

Maureen T. Stewart, Shay M. Daily, Lee Panas, Sage R. Feltus, Margaret Lee, Grant A. Ritter, Sharon Reif   +6 more
openalex   +2 more sources

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features. [PDF]

J Am Med Inform Assoc
Nateghi Haredasht F, Lopez I, Tate S, Ashtari P, Chan MM, Kulkarni D, Chen CA, Vangala M, Griffith K, Bunning B, Miner AS, Hernandez-Boussard T, Humphreys K, Lembke A, Vance LA, Chen JH.   +15 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

"Trust and suspicion" client and provider perspectives on the acceptability of medication for opioid use disorder among people who inject drugs in Kampala, Uganda. [PDF]

Harm Reduct J
Mudiope P, Nanyeenya N, Okurut S, Twimukye A, Simon K, Mutamba Byamah B, Nangendo J, Alamo S, Makumbi F, Wanyenze R, Matovu JKB.   +10 more
europepmc   +1 more source

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, EarlyView.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source

Opioids, Addiction Treatment, and the Long Tail of Eugenics [PDF]

, 2019
Appleman, Laura I.
core  

Sample size requirements to evaluate policies in addiction research using interrupted time series analysis (ITS): Tools and guidance

Addiction, EarlyView.
Abstract Formal power calculations are rarely presented in interrupted time‐series (ITS) studies due to their technical complexity, creating a significant gap in methodological rigor. This paper aimed to make power and sample size determination more accessible for researchers, particularly in the field of addiction, by providing a suite of practical ...
Emma Beard, Jamie Brown, Lion Shahab
wiley   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Inpatient addiction care is associated with increased vaccinations, medication for opioid use disorder and naloxone prescribing among patients with infective endocarditis in a rural state. [PDF]

Addict Sci Clin Pract
Farkas EJ, Molina V, Mohoney B, Craig W, Schaumberg J, McAuliffe A, Thakarar K.   +6 more
europepmc   +1 more source